Friday, October 28, 2016

Zofran


See also: Generic Zofran ODT


Zofran is a brand name of ondansetron, approved by the FDA in the following formulation(s):


ZOFRAN (ondansetron hydrochloride - injectable; injection)



  • Manufacturer: GLAXOSMITHKLINE

    Approval date: January 4, 1991

    Strength(s): EQ 2MG BASE/ML [RLD][AP]

ZOFRAN (ondansetron hydrochloride - solution; oral)



  • Manufacturer: GLAXOSMITHKLINE

    Approval date: January 24, 1997

    Strength(s): EQ 4MG BASE/5ML [RLD][AA]

ZOFRAN (ondansetron hydrochloride - tablet; oral)



  • Manufacturer: GLAXOSMITHKLINE

    Approval date: December 31, 1992

    Strength(s): EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: GLAXOSMITHKLINE

    Approval date: August 27, 1999

    Strength(s): EQ 24MG BASE [RLD][AB]

Has a generic version of Zofran been approved?


A generic version of Zofran has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Zofran and have been approved by the FDA:


ondansetron hydrochloride injectable; injection



  • Manufacturer: APOTEX

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: APP PHARMS

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: BAXTER HLTHCARE

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: BEDFORD

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: EMCURE PHARMS

    Approval date: April 16, 2010

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: GLAND PHARMA LTD

    Approval date: September 25, 2009

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: HIKMA FARMACEUTICA

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: HOSPIRA

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: HOSPIRA

    Approval date: January 19, 2007

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: LANNETT

    Approval date: April 14, 2010

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: LANNETT

    Approval date: August 5, 2010

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: LUITPOLD

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: LUITPOLD

    Approval date: November 18, 2008

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: PFIZER

    Approval date: April 23, 2008

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: PLIVA HRVATSKA DOO

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: SANDOZ

    Approval date: June 27, 2007

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: SPECTRUM PHARMS

    Approval date: March 26, 2007

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: SUN PHARM INDS (IN)

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: TEVA

    Approval date: November 22, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: WOCKHARDT

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]

ondansetron hydrochloride solution; oral



  • Manufacturer: AMNEAL PHARMS

    Approval date: January 31, 2011

    Strength(s): EQ 4MG BASE/5ML [AA]


  • Manufacturer: APOTEX

    Approval date: June 25, 2007

    Strength(s): EQ 4MG BASE/5ML [AA]


  • Manufacturer: AUROBINDO PHARMA

    Approval date: November 28, 2007

    Strength(s): EQ 4MG BASE/5ML [AA]


  • Manufacturer: ROXANE

    Approval date: December 26, 2006

    Strength(s): EQ 4MG BASE/5ML [AA]


  • Manufacturer: SILARX

    Approval date: January 27, 2011

    Strength(s): EQ 4MG BASE/5ML [AA]


  • Manufacturer: TARO

    Approval date: November 30, 2007

    Strength(s): EQ 4MG BASE/5ML [AA]

ondansetron hydrochloride tablet; oral



  • Manufacturer: APOTEX

    Approval date: June 25, 2007

    Strength(s): EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: AUROBINDO PHARMA

    Approval date: July 31, 2007

    Strength(s): EQ 24MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: DR REDDYS LABS LTD

    Approval date: December 26, 2006

    Strength(s): EQ 24MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: GLENMARK GENERICS

    Approval date: June 25, 2007

    Strength(s): EQ 24MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: MYLAN

    Approval date: June 25, 2007

    Strength(s): EQ 24MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: NATCO PHARMA LTD

    Approval date: June 25, 2007

    Strength(s): EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: PAR PHARM

    Approval date: June 25, 2007

    Strength(s): EQ 24MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: PLIVA HRVATSKA DOO

    Approval date: June 25, 2007

    Strength(s): EQ 24MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: SANDOZ

    Approval date: June 25, 2007

    Strength(s): EQ 24MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: SUN PHARM INDS (IN)

    Approval date: June 25, 2007

    Strength(s): EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: TARO

    Approval date: March 28, 2011

    Strength(s): EQ 24MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: TEVA

    Approval date: June 25, 2007

    Strength(s): EQ 24MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: WEST WARD

    Approval date: September 6, 2007

    Strength(s): EQ 24MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]

ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE (ondansetron hydrochloride injectable; injection)



  • Manufacturer: APOTEX INC

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: APP PHARMS

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: BAXTER HLTHCARE

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: BEDFORD LABS

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: HIKMA FARMACEUTICA

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: HOSPIRA

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: LUITPOLD

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: LUITPOLD

    Approval date: November 18, 2008

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: PFIZER

    Approval date: April 23, 2008

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: SANDOZ

    Approval date: June 27, 2007

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: SUN PHARM INDS LTD

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: TARO PHARMS IRELAND

    Approval date: March 21, 2008

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: TEVA

    Approval date: November 22, 2006

    Strength(s): EQ 2MG BASE/ML [AP]


  • Manufacturer: WOCKHARDT

    Approval date: December 26, 2006

    Strength(s): EQ 2MG BASE/ML [AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zofran. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Process and composition using ondansetron
    Patent 5,344,658
    Issued: September 6, 1994
    Inventor(s): Collin; David T.
    Assignee(s): Glaxo Group Limited
    The invention relates to a process for reducing the crystal size of ondansetron hydrochloride dihydrate produced by crystallisation from solvent to a size which is suitable for effective distribution in a tablet blend, in particular 100% less that 250 .mu.m. The ondansetron hydrochloride dihydrate is desolvated by drying at elevated temperature and reduced or atmospheric pressure and is then rehydrated.
    Patent expiration dates:

    • September 6, 2011


    • March 6, 2012
      ✓ 
      Pediatric exclusivity




  • Oral compositions containing ondansetron
    Patent 5,854,270
    Issued: December 29, 1998
    Inventor(s): Gambhir; Renu
    Assignee(s): Glaxo Wellcome Inc.
    The invention relates to a liquid composition for oral administration comprising ondansetron or a pharmaceutically acceptable derivative thereof, a sweetener and one or more pharmaceutically acceptable excipients. The sweetener comprises one or more polyhydric alcohols and the pH of the combination lies in the range 2.0 to 5.0. Methods for the manufacture of such compositions and for their use in the treatment of conditions mediated through the action of 5-hydroxytryptamine (5 HT) at 5 HT.sub.3 receptors are also included.
    Patent expiration dates:

    • November 20, 2015
      ✓ 
      Patent use: RELIEF OF NAUSEA AND VOMITING
      ✓ 
      Drug product


    • May 20, 2016
      ✓ 
      Pediatric exclusivity



See also...

  • Zofran Consumer Information (Drugs.com)
  • Zofran Consumer Information (Wolters Kluwer)
  • Zofran Solution Consumer Information (Wolters Kluwer)
  • Zofran Tablets Consumer Information (Wolters Kluwer)
  • Zofran Consumer Information (Cerner Multum)
  • Zofran injection Consumer Information (Cerner Multum)
  • Zofran Advanced Consumer Information (Micromedex)
  • Zofran Oral, Oromucosal Advanced Consumer Information (Micromedex)
  • Zofran AHFS DI Monographs (ASHP)
  • Ondansetron Consumer Information (Drugs.com)
  • Ondansetron Consumer Information (Wolters Kluwer)
  • Ondansetron Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
  • Ondansetron Soluble Film Consumer Information (Wolters Kluwer)
  • Ondansetron Solution Consumer Information (Wolters Kluwer)
  • Ondansetron Tablets Consumer Information (Wolters Kluwer)
  • Ondansetron Consumer Information (Cerner Multum)
  • Ondansetron injection Consumer Information (Cerner Multum)
  • Ondansetron Oral, Injection, Intravenous Advanced Consumer Information (Micromedex)
  • Ondansetron Oral, Oromucosal Advanced Consumer Information (Micromedex)
  • Ondansetron Hydrochloride AHFS DI Monographs (ASHP)

Donashin




Donashin may be available in the countries listed below.


Ingredient matches for Donashin



Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Donashin in the following countries:


  • Japan

International Drug Name Search


Vifenac




Vifenac may be available in the countries listed below.


Ingredient matches for Vifenac



Diclofenac

Diclofenac hydroxyethylpyrrolidine (a derivative of Diclofenac) is reported as an ingredient of Vifenac in the following countries:


  • Switzerland

Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Vifenac in the following countries:


  • Switzerland

International Drug Name Search


Sulfafurazol




Sulfafurazol may be available in the countries listed below.


Ingredient matches for Sulfafurazol



Sulfafurazole

Sulfafurazol (DCF) is also known as Sulfafurazole (Prop.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Prop.INNProposed International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Gamma-aminobutyric acid reuptake inhibitors


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Gamma-Aminobutyric acid (GABA) reuptake inhibitors are analogs of gamma-Aminobutyric acid that bind to gamma-aminobutyric acid transporters and inhibit GABA reuptake. This increases extracellular levels of GABA and enhances GABA mediated synaptic activity in the brain.


Gamma-Aminobutyric acid reuptake inhibitors are used as anticonvulsant agents to treat epilepsy.

See also

Medical conditions associated with gamma-aminobutyric acid reuptake inhibitors:

  • Seizures

Drug List:


Hobs




Hobs may be available in the countries listed below.


Ingredient matches for Hobs



Ulobetasol

Ulobetasol propionate (a derivative of Ulobetasol) is reported as an ingredient of Hobs in the following countries:


  • India

International Drug Name Search


Thursday, October 27, 2016

Nitazoxanida




Nitazoxanida may be available in the countries listed below.


Ingredient matches for Nitazoxanida



Nitazoxanide

Nitazoxanide is reported as an ingredient of Nitazoxanida in the following countries:


  • Argentina

International Drug Name Search


Hydrocutan Tabletten




Hydrocutan Tabletten may be available in the countries listed below.


Ingredient matches for Hydrocutan Tabletten



Hydrocortisone

Hydrocortisone is reported as an ingredient of Hydrocutan Tabletten in the following countries:


  • Germany

International Drug Name Search


Zidonil




Zidonil may be available in the countries listed below.


Ingredient matches for Zidonil



Fluconazole

Fluconazole is reported as an ingredient of Zidonil in the following countries:


  • Greece

International Drug Name Search


Noloten




Noloten may be available in the countries listed below.


Ingredient matches for Noloten



Amlodipine

Amlodipine is reported as an ingredient of Noloten in the following countries:


  • Ecuador

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Noloten in the following countries:


  • Peru

International Drug Name Search


Sarnacur




Sarnacur may be available in the countries listed below.


Ingredient matches for Sarnacur



Benzyl Benzoate

Benzyl Benzoate is reported as an ingredient of Sarnacur in the following countries:


  • Peru

International Drug Name Search


Chronic Active Hepatitis Medications


Definition of Chronic Active Hepatitis: This is a form of continuing liver inflammation that results in liver cell death. Causes include viral infection

Drugs associated with Chronic Active Hepatitis

The following drugs and medications are in some way related to, or used in the treatment of Chronic Active Hepatitis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Chronic Active Hepatitis





Drug List:


Victrelis


Victrelis is a brand name of boceprevir, approved by the FDA in the following formulation(s):


VICTRELIS (boceprevir - capsule; oral)



  • Manufacturer: SCHERING

    Approval date: May 13, 2011

    Strength(s): 200MG [RLD]

Has a generic version of Victrelis been approved?


No. There is currently no therapeutically equivalent version of Victrelis available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Victrelis. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Peptides as NS3-serine protease inhibitors of hepatitis C virus
    Patent 7,012,066
    Issued: March 14, 2006
    Inventor(s): Saksena; Anil K. & Girijavallabhan; Viyyoor Moopil & Lovey; Raymond G. & Jao; Edwin & Bennett; Frank & Mc Cormick; Jinping L. & Wang; Haiyan & Pike; Russell E. & Bogen; Stephane L. & Chan; Tin-Yau & Liu; Yi-Tsung & Zhu; Zhaoning & Njoroge; F. George & Arasappan; Ashok & Parekh; Teja
    Assignee(s): Schering Corporation
    Dendreon Corporation
    The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
    Patent expiration dates:

    • February 22, 2022
      ✓ 
      Patent use: TREATMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPE 1 INFECTION IN COMBINATION WITH PEGINTERFERON ALFA AND RIBAVIRIN IN ADULT PATIENTS (>=18 YEARS OF AGE) WITH COMPENSATED LIVER DISEASE
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Pharmaceutical formulations and methods of treatment using the same
    Patent 7,772,178
    Issued: August 10, 2010
    Inventor(s): Malcolm; Bruce A. & Bradley; Prudence K. & Pavlovsky; Anastasia & Cho; Wing-Kee Philip & Qiu; Zhihui
    Assignee(s): Schering Corporation
    Pharmaceutical formulations containing at least one compound of Formulae I-XXVI herein and at least one surfactant. Pharmaceutically acceptable carriers and excipients may also be included in the formulations. The formulations of the present invention are suited for use in single unit dosages.
    Patent expiration dates:

    • November 11, 2027
      ✓ 
      Patent use: TREATMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPE 1 INFECTION IN COMBINATION WITH PEGINTERFERON ALFA AND RIBAVIRIN IN ADULT PATIENTS (>=18 YEARS OF AGE) WITH COMPENSATED LIVER DISEASE
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • May 13, 2016 - NEW CHEMICAL ENTITY

See also...

  • Victrelis Consumer Information (Drugs.com)
  • Victrelis Consumer Information (Wolters Kluwer)
  • Victrelis Consumer Information (Cerner Multum)
  • Boceprevir Consumer Information (Wolters Kluwer)
  • Boceprevir Consumer Information (Cerner Multum)

Oratrol




Oratrol may be available in the countries listed below.


Ingredient matches for Oratrol



Diclofenamide

Diclofenamide is reported as an ingredient of Oratrol in the following countries:


  • Luxembourg

International Drug Name Search


Wednesday, October 26, 2016

Bone Marrow Transplantation Medications


Definition of Bone Marrow Transplantation: Bone marrow transplantation is a medical procedure that involves stem cell transplantation. The common feature of recipients is a need for blood stem cells. Most recipients are leukemia patients or others who have been exposed to high doses of chemotherapy or total body irradiation resulting in destruction of their bone marrow stem cells. Other patients who receive bone marrow transplants include pediatric cases where the patient has an inborn defect such as severe combined immunodeficiency or congenital neutropenia and was born with either no blood stem cells or defective stem cells. Other conditions that bone marrow transplants are considered for include thalassemia major, sickle cell disease and aplastic anemia.

Drugs associated with Bone Marrow Transplantation

The following drugs and medications are in some way related to, or used in the treatment of Bone Marrow Transplantation. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-topics

Topics under Bone Marrow Transplantation

  • Bone Marrow Transplantation, Failure or Engraftment Delay (1 drug)

  • Bone Marrow Transplantation, Myeloid Reconstruction (1 drug)

  • Infection Prophylaxis, Bone Marrow Transplantation (0 drugs)

Learn more about Bone Marrow Transplantation





Drug List:


Vit Estérone




Vit Estérone may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vit Estérone



Progesterone

Progesterone is reported as an ingredient of Vit Estérone in the following countries:


  • France

Tocopherol, α-

Tocopherol, α- acetate (a derivative of Tocopherol, α-) is reported as an ingredient of Vit Estérone in the following countries:


  • France

International Drug Name Search


Synapause E




Synapause E may be available in the countries listed below.


Ingredient matches for Synapause E



Estriol

Estriol is reported as an ingredient of Synapause E in the following countries:


  • Netherlands

International Drug Name Search


Nitrolingual protect ISMN




Nitrolingual protect ISMN may be available in the countries listed below.


Ingredient matches for Nitrolingual protect ISMN



Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Nitrolingual protect ISMN in the following countries:


  • Germany

International Drug Name Search


Stadol




In the US, Stadol (butorphanol systemic) is a member of the drug class narcotic analgesics and is used to treat Anesthesia, Anesthetic Adjunct, Labor Pain and Pain.

US matches:

  • Stadol Solution

  • Stadol NS nasal

  • Stadol injection

  • Stadol

  • Stadol NS

Ingredient matches for Stadol



Butorphanol

Butorphanol tartrate (a derivative of Butorphanol) is reported as an ingredient of Stadol in the following countries:


  • Egypt

  • Japan

  • Philippines

  • Russian Federation

  • United States

International Drug Name Search


Nichogencin




Nichogencin may be available in the countries listed below.


Ingredient matches for Nichogencin



Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Nichogencin in the following countries:


  • Indonesia

International Drug Name Search


Cordran


See also: Generic Cordran SP


Cordran is a brand name of flurandrenolide topical, approved by the FDA in the following formulation(s):


CORDRAN (flurandrenolide - lotion; topical)



  • Manufacturer: WATSON LABS

    Approved Prior to Jan 1, 1982

    Strength(s): 0.05% [RLD]

CORDRAN (flurandrenolide - tape; topical)



  • Manufacturer: WATSON PHARMS

    Approved Prior to Jan 1, 1982

    Strength(s): 0.004MG/SQ CM [RLD]

Has a generic version of Cordran been approved?


No. There is currently no therapeutically equivalent version of Cordran available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cordran. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Cordran.

See also...

  • Cordran Cream Consumer Information (Wolters Kluwer)
  • Cordran Lotion Consumer Information (Wolters Kluwer)
  • Cordran Consumer Information (Cerner Multum)
  • Cordran Advanced Consumer Information (Micromedex)
  • Cordran AHFS DI Monographs (ASHP)
  • Flurandrenolide Cream Consumer Information (Wolters Kluwer)
  • Flurandrenolide Lotion Consumer Information (Wolters Kluwer)
  • Flurandrenolide Tape Consumer Information (Wolters Kluwer)
  • Flurandrenolide topical Consumer Information (Cerner Multum)
  • Drenison Advanced Consumer Information (Micromedex)
  • Drenison 1/4 Advanced Consumer Information (Micromedex)
  • Drenison Tape Advanced Consumer Information (Micromedex)
  • Flurandrenolide Topical application Advanced Consumer Information (Micromedex)
  • Flurandrenolide AHFS DI Monographs (ASHP)

Scalphen




Scalphen may be available in the countries listed below.


Ingredient matches for Scalphen



Mesulfen

Mesulfen is reported as an ingredient of Scalphen in the following countries:


  • Taiwan

International Drug Name Search


Naaxia




Naaxia may be available in the countries listed below.


Ingredient matches for Naaxia



Spaglumic Acid

Spaglumic Acid sodium (a derivative of Spaglumic Acid) is reported as an ingredient of Naaxia in the following countries:


  • Chile

  • Czech Republic

  • France

  • Greece

  • Hong Kong

  • Hungary

  • Italy

  • Portugal

  • Romania

  • Slovakia

  • Spain

  • Turkey

International Drug Name Search


Tuesday, October 25, 2016

Bulimia Medications


Definition of Bulimia:

Bulimia is an illness defined by food binges, or recurrent episodes of significant overeating, that are accompanied by a sense of loss of control. The affected person then uses various methods -- such as vomiting or laxative abuse -- to prevent weight gain.


Someone with bulimia may also suffer from anorexia nervosa, an eating disorder involving severe, chronic weight loss that proceeds to starvation, but many bulimics do not suffer from anorexia.

More...

Drugs associated with Bulimia

The following drugs and medications are in some way related to, or used in the treatment of Bulimia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Bulimia





Drug List:


Nelbon




Nelbon may be available in the countries listed below.


Ingredient matches for Nelbon



Nitrazepam

Nitrazepam is reported as an ingredient of Nelbon in the following countries:


  • Japan

International Drug Name Search


Hydroxyprogestérone




Hydroxyprogestérone may be available in the countries listed below.


Ingredient matches for Hydroxyprogestérone



Hydroxyprogesterone

Hydroxyprogestérone (DCF) is known as Hydroxyprogesterone in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Diviseg




Diviseg may be available in the countries listed below.


Ingredient matches for Diviseg



Estradiol

Estradiol 17ß-valerate (a derivative of Estradiol) is reported as an ingredient of Diviseg in the following countries:


  • Slovakia

Medroxyprogesterone

Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of Diviseg in the following countries:


  • Slovakia

International Drug Name Search


Sodium Ozagrel




Sodium Ozagrel may be available in the countries listed below.


Ingredient matches for Sodium Ozagrel



Ozagrel

Ozagrel sodium (a derivative of Ozagrel) is reported as an ingredient of Sodium Ozagrel in the following countries:


  • Japan

International Drug Name Search


Vogalib




Vogalib may be available in the countries listed below.


Ingredient matches for Vogalib



Metopimazine

Metopimazine is reported as an ingredient of Vogalib in the following countries:


  • France

International Drug Name Search


Sonidal




Sonidal may be available in the countries listed below.


Ingredient matches for Sonidal



Budesonide

Budesonide is reported as an ingredient of Sonidal in the following countries:


  • Greece

International Drug Name Search


Dirastan




Dirastan may be available in the countries listed below.


Ingredient matches for Dirastan



Tolbutamide

Tolbutamide is reported as an ingredient of Dirastan in the following countries:


  • Czech Republic

International Drug Name Search


Daltrizen




Daltrizen may be available in the countries listed below.


Ingredient matches for Daltrizen



Dacarbazine

Dacarbazine is reported as an ingredient of Daltrizen in the following countries:


  • Romania

International Drug Name Search


Monday, October 24, 2016

Solvente Indoloro Apolo




Solvente Indoloro Apolo may be available in the countries listed below.


Ingredient matches for Solvente Indoloro Apolo



Lidocaine

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Solvente Indoloro Apolo in the following countries:


  • Argentina

International Drug Name Search


Uvitriam




Uvitriam may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Uvitriam



Triamcinolone

Triamcinolone 16α,17α-acetonide (a derivative of Triamcinolone) is reported as an ingredient of Uvitriam in the following countries:


  • Italy

International Drug Name Search


Noofen




Noofen may be available in the countries listed below.


Ingredient matches for Noofen



4-Amino-3-phenylbutyric acid

4-Amino-3-phenylbutyric acid is reported as an ingredient of Noofen in the following countries:


  • Latvia

International Drug Name Search


Suril




Suril may be available in the countries listed below.


Ingredient matches for Suril



Sucralfate

Sucralfate is reported as an ingredient of Suril in the following countries:


  • Italy

International Drug Name Search


Vetaket




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vetaket



Ketamine

Ketamine hydrochloride (a derivative of Ketamine) is reported as an ingredient of Vetaket in the following countries:


  • United States

International Drug Name Search


Miscellaneous metabolic agents


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

See also

Medical conditions associated with miscellaneous metabolic agents:

  • Gaucher Disease
  • Phenylketonuria

Drug List:


Stable and Kennel Disinfectant




Stable and Kennel Disinfectant may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Stable and Kennel Disinfectant



Benzalkonium Chloride

Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Stable and Kennel Disinfectant in the following countries:


  • Australia

International Drug Name Search


Decoquinate




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0018507-89-6

Chemical Formula

C24-H35-N-O5

Molecular Weight

417

Therapeutic Category

Antiprotozoal: Agent against coccidiosis

Chemical Name

3-Quinolinecarboxylic acid, 6-(decyloxy)-7-ethoxy-4-hydroxy-, ethyl ester

Foreign Names

  • Decoquinatum (Latin)
  • Decoquinat (German)
  • Décoquinate (French)
  • Decoquinato (Spanish)

Generic Names

  • Decoquinate (OS: USAN, BAN)
  • HC 1528 (IS: HessClark)
  • M & B 15497 (IS: MayBaker)
  • Decoquinate (PH: BP vet. 2007, USP 32)

Brand Names

  • 3 Nitro (Decoquinate and Roxarsone (veterinary use))
    Alpharma Animal Health, United States


  • Acti Decocci (veterinary use)
    Laboratoires Biové, France


  • Albac (Decoquinate and Bacitracin (veterinary use))
    Alpharma Animal Health, United States


  • Aureomycin (Decoquinate and Chlortetracycline (veterinary use))
    Alpharma Animal Health, United States


  • BMD (Decoquinate and Bacitracin (veterinary use))
    Alpharma Animal Health, United States


  • Broiler (Decoquinate and Bacitracin (veterinary use))
    Alpharma Animal Health, United States


  • Chlormax (Decoquinate and Chlortetracycline (veterinary use))
    Alpharma Animal Health, United States


  • Chloromax (Decoquinate and Chlortetracycline (veterinary use))
    Alpharma Animal Health, United States


  • Deccox (Decoquinate and Bacitracin (veterinary use))
    Alpharma Animal Health, United States; Alpharma Animal Health, United States


  • Deccox (Decoquinate and Chlortetracycline (veterinary use))
    Alpharma Animal Health, United States; Pennfield, United States


  • Deccox (Decoquinate and Lincomycin (veterinary use))
    Alpharma Animal Health, United States; Pharmacia & Upjohn vet, United States


  • Deccox (Decoquinate and Monensin (veterinary use))
    Alpharma Animal Health, United States


  • Deccox (Decoquinate and Roxarsone (veterinary use))
    Alpharma Animal Health, United States


  • Deccox (veterinary use)
    Alpharma, France; Alpharma Animal Health, United States; APS Specialty Chemicals, New Zealand; Filozoo, Italy; Forum, United Kingdom; Forum, Ireland; Instavet, South Africa


  • Decoquinate & Chlortetracycline (Decoquinate and Chlortetracycline (veterinary use))
    Alpharma Animal Health, United States


  • Decoquinate & Lincomycin (Decoquinate and Lincomycin (veterinary use))
    Alpharma Animal Health, United States


  • Décoquinate (veterinary use)
    Laboratoires Franvet, France


  • Decox (veterinary use)
    Alpharma, United Kingdom; Forum, United Kingdom


  • Lincomix (Decoquinate and Lincomycin (veterinary use))
    Pharmacia & Upjohn vet, United States


  • Lincomycin (Decoquinate and Lincomycin (veterinary use))
    Alpharma Animal Health, United States


  • Pennchlor (Decoquinate and Chlortetracyclin (veterinary use))
    Pennfield, United States


  • Rumensin (Decoquinate and Monensin (veterinary use))
    Alpharma Animal Health, United States


  • Rumicox (veterinary use)
    Sogeval, France

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Neurostil




Neurostil may be available in the countries listed below.


Ingredient matches for Neurostil



Gabapentin

Gabapentin is reported as an ingredient of Neurostil in the following countries:


  • Ireland

International Drug Name Search


Destrometorfano Bromidrato FederFARMA. CO




Destrometorfano Bromidrato FederFARMA.CO may be available in the countries listed below.


Ingredient matches for Destrometorfano Bromidrato FederFARMA.CO



Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Destrometorfano Bromidrato FederFARMA.CO in the following countries:


  • Italy

International Drug Name Search


SaveHeart




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for SaveHeart



Milbemycin Oxime

Milbemycin Oxime is reported as an ingredient of SaveHeart in the following countries:


  • United States

International Drug Name Search


Sunday, October 23, 2016

Sumatriptan-1A Pharma




Sumatriptan-1A Pharma may be available in the countries listed below.


Ingredient matches for Sumatriptan-1A Pharma



Sumatriptan

Sumatriptan is reported as an ingredient of Sumatriptan-1A Pharma in the following countries:


  • Poland

Sumatriptan succinate (a derivative of Sumatriptan) is reported as an ingredient of Sumatriptan-1A Pharma in the following countries:


  • Austria

  • Germany

International Drug Name Search


Sulidamor




Sulidamor may be available in the countries listed below.


Ingredient matches for Sulidamor



Nimesulide

Nimesulide is reported as an ingredient of Sulidamor in the following countries:


  • Italy

International Drug Name Search


Danovir




Danovir may be available in the countries listed below.


Ingredient matches for Danovir



Acyclovir

Aciclovir is reported as an ingredient of Danovir in the following countries:


  • Indonesia

International Drug Name Search


Daunorubicin Pfizer




Daunorubicin Pfizer may be available in the countries listed below.


Ingredient matches for Daunorubicin Pfizer



Daunorubicin

Daunorubicin hydrochloride (a derivative of Daunorubicin) is reported as an ingredient of Daunorubicin Pfizer in the following countries:


  • Singapore

International Drug Name Search


Sanorin




Sanorin may be available in the countries listed below.


Ingredient matches for Sanorin



Naphazoline

Naphazoline nitrate (a derivative of Naphazoline) is reported as an ingredient of Sanorin in the following countries:


  • Czech Republic

  • Estonia

  • Georgia

  • Latvia

  • Lithuania

  • Slovakia

International Drug Name Search


Stud




Stud may be available in the countries listed below.


Ingredient matches for Stud



Lidocaine

Lidocaine is reported as an ingredient of Stud in the following countries:


  • Israel

International Drug Name Search


Saturday, October 22, 2016

Nasal Carriage of Staphylococcus aureus Medications


Drugs associated with Nasal Carriage of Staphylococcus aureus

The following drugs and medications are in some way related to, or used in the treatment of Nasal Carriage of Staphylococcus aureus. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Peptic Ulcer with Hemorrhage/Perforation/Obstruction Medications


Topics under Peptic Ulcer with Hemorrhage/Perforation/Obstruction

  • Peptic Ulcer with Hemorrhage (0 drugs in 3 topics)

  • Peptic Ulcer with Obstruction (0 drugs)

  • Peptic Ulcer with Perforation (0 drugs in 2 topics)

Learn more about Peptic Ulcer with Hemorrhage/Perforation/Obstruction





Drug List:


Dilzem Parenteral




Dilzem Parenteral may be available in the countries listed below.


Ingredient matches for Dilzem Parenteral



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Dilzem Parenteral in the following countries:


  • Bulgaria

  • Romania

International Drug Name Search


Nalgesic




Nalgesic may be available in the countries listed below.


Ingredient matches for Nalgesic



Piroxicam

Piroxicam is reported as an ingredient of Nalgesic in the following countries:


  • Argentina

International Drug Name Search


Stopatik




Stopatik may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Stopatik



Cypermethrin

Cypermethrin is reported as an ingredient of Stopatik in the following countries:


  • South Africa

Piperonyl Butoxide

Piperonyl Butoxide is reported as an ingredient of Stopatik in the following countries:


  • South Africa

International Drug Name Search


Yzfero




Yzfero may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Yzfero



Dextriferron

Dextriferron is reported as an ingredient of Yzfero in the following countries:


  • China

International Drug Name Search


Nurabax




Nurabax may be available in the countries listed below.


Ingredient matches for Nurabax



Gabapentin

Gabapentin is reported as an ingredient of Nurabax in the following countries:


  • Estonia

  • Latvia

  • Lithuania

  • Slovakia

International Drug Name Search


Friday, October 21, 2016

Doxalpha




Doxalpha may be available in the countries listed below.


Ingredient matches for Doxalpha



Cromoglicic Acid

Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of Doxalpha in the following countries:


  • Greece

International Drug Name Search


Vitamec D3




Vitamec D3 may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vitamec D3



Colecalciferol

Colecalciferol is reported as an ingredient of Vitamec D3 in the following countries:


  • Australia

International Drug Name Search


Deponit




In the US, Deponit is a member of the following drug classes: antianginal agents, vasodilators and is used to treat Angina, Angina Pectoris Prophylaxis, Heart Attack, Heart Failure and High Blood Pressure.

UK matches:

  • Deponit 10 (SPC)
  • Deponit 5 (SPC)

Ingredient matches for Deponit



Nitroglycerin

Nitroglycerin is reported as an ingredient of Deponit in the following countries:


  • Austria

  • Belgium

  • China

  • Finland

  • Germany

  • Hong Kong

  • Israel

  • Italy

  • Lithuania

  • Luxembourg

  • Malaysia

  • Netherlands

  • Peru

  • Philippines

  • Singapore

  • Sri Lanka

  • Switzerland

  • United Kingdom

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Cardioselective beta blockers


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Beta adrenergic blocking agents prevent stimulation of the beta adrenergic receptors at the nerve endings of the sympathetic nervous system and therefore decrease the activity of the heart. They block sympathetic stimulation of the heart and reduce systolic pressure, heart rate, cardiac contractility and output, so decrease myocardial oxygen demand and increase exercise tolerance.


Beta adrenergic blocking agents are used to treat angina, control abnormal heart rhythms and to reduce high blood pressure. However, blocking of the beta receptors may cause bronchial constriction therefore care has to be taken with the use of beta blockers in patients with respiratory conditions.


Cardioselective beta blockers (beta1- selective blockers) have a clinical advantage in that they mainly affect the heart, which predominantly has beta1 receptors. The effect of broncho-constriction is less with beta1 selective blockers, as the bronchial muscle has more beta2 receptors, however the danger of broncho-constriction cannot be totally ignored, as they are not totally selective.

See also

Medical conditions associated with cardioselective beta blockers:

  • Alcohol Withdrawal
  • Angina
  • Angina Pectoris Prophylaxis
  • Anxiety
  • Atrial Fibrillation
  • Atrial Flutter
  • Benign Essential Tremor
  • Esophageal Variceal Hemorrhage Prophylaxis
  • Heart Attack
  • Heart Failure
  • High Blood Pressure
  • Intra- or Post-op SVT or Hypertension
  • Left Ventricular Dysfunction
  • Migraine Prevention
  • Mitral Valve Prolapse
  • Premature Ventricular Depolarizations
  • Supraventricular Tachycardia
  • Ventricular Tachycardia

Drug List:


Harmonet




Harmonet may be available in the countries listed below.


Ingredient matches for Harmonet



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Harmonet in the following countries:


  • Belgium

  • Colombia

  • Denmark

  • Estonia

  • France

  • Hungary

  • Italy

  • Latvia

  • Lithuania

  • Portugal

  • Slovenia

  • Spain

  • Switzerland

  • Venezuela

Gestodene

Gestodene is reported as an ingredient of Harmonet in the following countries:


  • Belgium

  • Colombia

  • Denmark

  • Estonia

  • France

  • Hungary

  • Italy

  • Latvia

  • Lithuania

  • Portugal

  • Slovakia

  • Slovenia

  • Spain

  • Switzerland

  • Venezuela

International Drug Name Search


Sandoz Ticlopidine




Sandoz Ticlopidine may be available in the countries listed below.


Ingredient matches for Sandoz Ticlopidine



Ticlopidine

Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Sandoz Ticlopidine in the following countries:


  • Canada

International Drug Name Search


Thursday, October 20, 2016

Vitamin B1




In some countries, this medicine may only be approved for veterinary use.


In the US, Vitamin B1 is a member of the drug class vitamins and is used to treat Beriberi, Vitamin B1 Deficiency, Vitamin/Mineral Supplementation and Deficiency and Wernicke's Encephalopathy.

Ingredient matches for Vitamin B1



Thiamine

Thiamine is reported as an ingredient of Vitamin B1 in the following countries:


  • Bosnia & Herzegowina

  • Ethiopia

  • Serbia

Thiamine hydrochloride (a derivative of Thiamine) is reported as an ingredient of Vitamin B1 in the following countries:


  • Australia

  • Georgia

  • Hungary

  • Ireland

  • Japan

  • Latvia

  • Serbia

  • Taiwan

  • United Kingdom

International Drug Name Search


Shegest




Shegest may be available in the countries listed below.


Ingredient matches for Shegest



Allylestrenol

Allylestrenol is reported as an ingredient of Shegest in the following countries:


  • India

International Drug Name Search


Vitamina C




Vitamina C may be available in the countries listed below.


Ingredient matches for Vitamina C



Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Vitamina C in the following countries:


  • Argentina

  • Brazil

  • Chile

  • Colombia

  • Peru

  • Poland

  • Romania

  • Venezuela

International Drug Name Search


Pneumocystis Pneumonia Prophylaxis Medications


Drugs associated with Pneumocystis Pneumonia Prophylaxis

The following drugs and medications are in some way related to, or used in the treatment of Pneumocystis Pneumonia Prophylaxis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Wednesday, October 19, 2016

Dospan-Pento




Dospan-Pento may be available in the countries listed below.


Ingredient matches for Dospan-Pento



Pentoxifylline

Pentoxifylline is reported as an ingredient of Dospan-Pento in the following countries:


  • Argentina

International Drug Name Search


Natura Insecticidal Collar




Natura Insecticidal Collar may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Natura Insecticidal Collar



Permethrin

Permethrin is reported as an ingredient of Natura Insecticidal Collar in the following countries:


  • United Kingdom

International Drug Name Search


Dolofur




Dolofur may be available in the countries listed below.


Ingredient matches for Dolofur



Metamizole

Metamizole sodium monohydrate (a derivative of Metamizole) is reported as an ingredient of Dolofur in the following countries:


  • Mexico

International Drug Name Search


Vigabatrine




Vigabatrine may be available in the countries listed below.


Ingredient matches for Vigabatrine



Vigabatrin

Vigabatrine (DCF) is known as Vigabatrin in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Valproate Sodium 1A Pharma




Valproate Sodium 1A Pharma may be available in the countries listed below.


Ingredient matches for Valproate Sodium 1A Pharma



Valproic Acid

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Valproate Sodium 1A Pharma in the following countries:


  • Estonia

  • Latvia

International Drug Name Search


Nonoccupational Exposure Medications


Drugs associated with Nonoccupational Exposure

The following drugs and medications are in some way related to, or used in the treatment of Nonoccupational Exposure. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Dalacin Vaginal




Dalacin Vaginal may be available in the countries listed below.


Ingredient matches for Dalacin Vaginal



Clindamycin

Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Dalacin Vaginal in the following countries:


  • Luxembourg

International Drug Name Search


Ovranette




Ovranette may be available in the countries listed below.


UK matches:

  • Ovranette 150/30 micrograms Coated Tablets

Ingredient matches for Ovranette



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Ovranette in the following countries:


  • Austria

  • United Kingdom

Levonorgestrel

Levonorgestrel is reported as an ingredient of Ovranette in the following countries:


  • Austria

  • United Kingdom

International Drug Name Search


Quinapril Cinfamed




Quinapril Cinfamed may be available in the countries listed below.


Ingredient matches for Quinapril Cinfamed



Quinapril

Quinapril hydrochloride (a derivative of Quinapril) is reported as an ingredient of Quinapril Cinfamed in the following countries:


  • Spain

International Drug Name Search


Wydora




Wydora may be available in the countries listed below.


Ingredient matches for Wydora



Indoramin

Indoramin hydrochloride (a derivative of Indoramin) is reported as an ingredient of Wydora in the following countries:


  • Germany

International Drug Name Search


Doxat




Doxat may be available in the countries listed below.


Ingredient matches for Doxat



Doxycycline

Doxycycline is reported as an ingredient of Doxat in the following countries:


  • Bulgaria

Doxycycline hydrochloride (a derivative of Doxycycline) is reported as an ingredient of Doxat in the following countries:


  • Malta

International Drug Name Search


Suvic




Suvic may be available in the countries listed below.


Ingredient matches for Suvic



Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Suvic in the following countries:


  • Bangladesh

International Drug Name Search


Tuesday, October 18, 2016

Nemirostad




Nemirostad may be available in the countries listed below.


Ingredient matches for Nemirostad



Nebivolol

Nebivolol is reported as an ingredient of Nemirostad in the following countries:


  • Lithuania

Nebivolol hydrochloride (a derivative of Nebivolol) is reported as an ingredient of Nemirostad in the following countries:


  • Estonia

  • Latvia

International Drug Name Search


Novalgina




Novalgina may be available in the countries listed below.


Ingredient matches for Novalgina



Metamizole

Metamizole sodium monohydrate (a derivative of Metamizole) is reported as an ingredient of Novalgina in the following countries:


  • Argentina

  • Brazil

  • Colombia

  • Costa Rica

  • Dominican Republic

  • Ecuador

  • El Salvador

  • Guatemala

  • Honduras

  • Italy

  • Nicaragua

  • Panama

  • Peru

International Drug Name Search


Silece




Silece may be available in the countries listed below.


Ingredient matches for Silece



Flunitrazepam

Flunitrazepam is reported as an ingredient of Silece in the following countries:


  • Japan

International Drug Name Search


Veracef




Veracef may be available in the countries listed below.


Ingredient matches for Veracef



Cefradine

Cefradine is reported as an ingredient of Veracef in the following countries:


  • Colombia

  • Venezuela

International Drug Name Search


Nitrazepam-neuraxpharm




Nitrazepam-neuraxpharm may be available in the countries listed below.


Ingredient matches for Nitrazepam-neuraxpharm



Nitrazepam

Nitrazepam is reported as an ingredient of Nitrazepam-neuraxpharm in the following countries:


  • Germany

International Drug Name Search


Ovcon




Ingredient matches for Ovcon



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Ovcon in the following countries:


  • United States

Norethisterone

Norethisterone is reported as an ingredient of Ovcon in the following countries:


  • United States

International Drug Name Search


Monday, October 17, 2016

Divask




Divask may be available in the countries listed below.


Ingredient matches for Divask



Amlodipine

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Divask in the following countries:


  • Indonesia

International Drug Name Search


Oseum




Oseum may be available in the countries listed below.


Ingredient matches for Oseum



Calcitonin

Calcitonin is reported as an ingredient of Oseum in the following countries:


  • Mexico

International Drug Name Search


Strophanthin-K




CAS registry number (Chemical Abstracts Service)

0011005-63-3

Therapeutic Category

Cardiac glycoside

Chemical Name

Mixture of K-Strophanthin α, ß, and gamma.

Foreign Name

  • k-Strophanthin (German)

Generic Names

  • Cymarine (IS)
  • Strofan-K (IS)
  • Strofantina K (PH: F.U. IX)

Brand Names

  • Kombetin
    Roche, Italy


  • Strophanthin K Double-Crane Pharm
    Double-Crane, China


  • Strophantin
    Halychpharm, Georgia

International Drug Name Search

Glossary

ISInofficial Synonym
PHPharmacopoeia Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Valederm




Valederm may be available in the countries listed below.


Ingredient matches for Valederm



Betamethasone

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Valederm in the following countries:


  • Argentina

International Drug Name Search


Dalzad




Dalzad may be available in the countries listed below.


Ingredient matches for Dalzad



Valsartan

Valsartan is reported as an ingredient of Dalzad in the following countries:


  • Greece

International Drug Name Search